Inhalation & Respiratory Drug Delivery USA Congress Inhalation & Respiratory Drug Delivery USA Congress

Oxford Global Conferences are proud to present our Inhalation & Respiratory Drug Delivery USA Congress, 12 – 13 March 2018, San Diego, USA with our co-located Formulation & Drug Delivery USA Congress. Across the two days, over 200 senior industry experts will present new trends in combination product design and the future directions of inhalation drug delivery research. Further discussion will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.

Including 2 interactive streams:

• Development & Formulation of Inhaled Therapies
• Inhalation Devices & Analytics

Inhalation & Respiratory Drug Delivery USA Congress Confirmed Speakers Include:

Xian-Ming Zeng, Executive Vice President & Head of Inhalation R&D
Lupin Inc.

Tushar Shah, Global Head of Respiratory R&D
Teva Pharmaceuticals

John Patton, Chairman and Chief Executive Officer
Dance Biopharm

Nestor Molfino, Chief Executive Officer
Pulmotect

Antonio Cabal, Principal Scientist
Merck

Jonathan Phillips, Principal Scientist
Amgen

Susan Hoe, Senior Scientist, Inhalation Product Development
Pearl Therapeutics

Ajit Narang, Senior Scientist
Genentech

Robert Sievers, Professor, Pharmaceutical Biotechnology
University of Colorado

Beth Laube, Professor of Pediatrics
John Hopkins University

For a full list of speakers, please visit our website.

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.